SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Increase (Decrease) in Due to Related Parties, Current
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) reported Increase (Decrease) in Due to Related Parties, Current of $361.13 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-09-24.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent · last filed 2026-09-24
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. increase (decrease) in due to related parties, current for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. increase (decrease) in due to related parties, current for the quarter ending 2024-09-30 was $0.00.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. increase (decrease) in due to related parties, current for the quarter ending 2024-06-30 was $0.00.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. increase (decrease) in due to related parties, current for the quarter ending 2024-03-31 was -$446.00.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. increase (decrease) in due to related parties, current for fiscal 2024 was -$446.00.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. increase (decrease) in due to related parties, current for fiscal 2023 was -$12.05K, a 196.43% decline from fiscal 2022.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. increase (decrease) in due to related parties, current for fiscal 2022 was $12.50K.
| Period end | Increase (Decrease) in Due to Related Parties, Current 3 month | Increase (Decrease) in Due to Related Parties, Current 6 month | Increase (Decrease) in Due to Related Parties, Current 9 month | Increase (Decrease) in Due to Related Parties, Current 12 month |
|---|---|---|---|---|
| 2026-06-30 | $361.13K 10-Q · filed 2026-09-24 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $0.00 derived: sum of 3 quarters · filed 2026-03-31 | -$446.00 10-K · filed 2026-03-31 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | -$446.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$446.00 10-Q · filed 2025-08-13 | $0.00 derived: sum of 3 quarters · filed 2025-08-13 | $0.00 derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | -$446.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2025-05-08 | $0.00 derived: sum of 3 quarters · filed 2025-05-08 | $0.00 derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $446.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $446.00 derived: sum of 2 quarters · filed 2025-02-26 | $446.00 derived: sum of 3 quarters · filed 2025-02-26 | -$12.05K 10-K · filed 2025-02-26 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $0.00 derived: sum of 2 quarters · filed 2024-11-13 | -$12.50K 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2024-09-04 | -$12.50K 10-Q · filed 2024-09-04 | ||
| 2023-03-31 | -$12.50K 10-Q/A · filed 2024-09-04 | |||
| 2022-12-31 | $12.50K 10-K/A · filed 2024-09-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |